Literature DB >> 16160184

Formation of vesicular stomatitis virus pseudotypes bearing surface proteins of hepatitis B virus.

Manujendra N Saha1, Atsushi Tanaka, Atsushi Jinno-Oue, Nobuaki Shimizu, Kazushi Tamura, Masahiko Shinagawa, Joe Chiba, Hiroo Hoshino.   

Abstract

It has been difficult to propagate and titrate hepatitis B virus (HBV) in tissue culture. We examined whether vesicular stomatitis virus (VSV) pseudotypes bearing HBV surface (HBs) proteins infectious for human cell lines could be prepared. For this, expression plasmids for three surface proteins, L, M, and S, of HBV were made. 293T cells were then transfected with these plasmids either individually or in different combinations. 293T cells expressing HBs proteins were infected with VSVdeltaG*-G, a recombinant VSV expressing green fluorescent protein (GFP), to make VSV pseudotypes. Culture supernatants together with cells were harvested and sonicated for a short time. The infectivities of freshly harvested supernatants were determined by quantifying the number of cells expressing GFP after neutralization with anti-VSV serum and mouse monoclonal antibodies (MAbs) against HBs protein. Among 14 cell lines tested for susceptibility to HBV pseudotype samples, HepG2, JHH-7, and 293T cells were judged to be the most susceptible. Namely, the infectious units (IU) of the culture supernatant samples neutralized with anti-VSV in the absence and presence of anti-HBs S MAbs and titrated on HepG2 cells ranged from 1,000 to 4,000 IU/ml and 200 to 400 IU/ml, respectively, suggesting the presence of VSVdeltaG*(HBV) pseudotypes. This infectivity was inhibited by treatment with lactoferrin or dextran sulfate. Pretreatment of the cells with trypsin or tunicamycin inhibited plating of the pseudotype samples. The HBV pseudotypes can be used to analyze early steps of HBV infection, including the entry mechanism of HBV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160184      PMCID: PMC1211511          DOI: 10.1128/JVI.79.19.12566-12574.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Evidence for structural differences in the S domain of L in comparison with S protein of hepatitis B virus.

Authors:  Reginald F Clayton; Ania Owsianka; Arvind H Patel
Journal:  J Gen Virol       Date:  2001-07       Impact factor: 3.891

2.  Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus.

Authors:  L M Lagging; K Meyer; R J Owens; R Ray
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

4.  Distinctive properties of the hepatitis B virus envelope proteins.

Authors:  K L Molnar-Kimber; V Jarocki-Witek; S K Dheer; S K Vernon; A J Conley; A R Davis; P P Hung
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

5.  A carboxy-terminal portion of the preS1 domain of hepatitis B virus (HBV) occasioned retention in endoplasmic reticulum of HBV envelope proteins expressed by recombinant vaccinia viruses.

Authors:  S Nĕmecková; D Kunke; M Press; V Nĕmecek; L Kutinová
Journal:  Virology       Date:  1994-08-01       Impact factor: 3.616

6.  Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera.

Authors:  P Clapham; K Nagy; R A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

7.  Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.

Authors:  S Z Salahuddin; P D Markham; F Wong-Staal; G Franchini; V S Kalyanaraman; R C Gallo
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

8.  Sulphated and sulphonated polymers inhibit the initial interaction of hepatitis B virus with hepatocytes.

Authors:  C Ying; J F Van Pelt; A Van Lommel; M Van Ranst; P Leyssen; E De Clercq; J Neyts
Journal:  Antivir Chem Chemother       Date:  2002-05

9.  Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum.

Authors:  E J Patzer; G R Nakamura; C C Simonsen; A D Levinson; R Brands
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

10.  Terminal transferase immunofluorescence, enzyme markers and immunological profile of human leukemia-lymphoma cell lines representing different levels of differentiation.

Authors:  B I Srivastava; J Minowada
Journal:  Leuk Res       Date:  1983       Impact factor: 3.156

View more
  4 in total

1.  Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes.

Authors:  Ning Chai; Ho Eun Chang; Emmanuelle Nicolas; Severin Gudima; Jinhong Chang; John Taylor
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

2.  Generation of VSV pseudotypes using recombinant ΔG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines.

Authors:  Michael A Whitt
Journal:  J Virol Methods       Date:  2010-08-13       Impact factor: 2.014

3.  Development and Applications of VSV Vectors Based on Cell Tropism.

Authors:  Hideki Tani; Shigeru Morikawa; Yoshiharu Matsuura
Journal:  Front Microbiol       Date:  2012-01-18       Impact factor: 5.640

4.  Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins.

Authors:  Masafumi Sakata; Hideki Tani; Masaki Anraku; Michiyo Kataoka; Noriyo Nagata; Fumio Seki; Maino Tahara; Noriyuki Otsuki; Kiyoko Okamoto; Makoto Takeda; Yoshio Mori
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.